Exagen (XGN) Change in Account Payables (2018 - 2026)
Exagen's (XGN) quarterly Change in Account Payables came in at -$41000.0 in Q1 2026, down 117.75% YoY from $231000.0 in Q1 2025, and down 106.98% on a QoQ basis from $587000.0 in Q4 2025.
Exagen (XGN) Change in Account Payables (2018 - 2026) Analysis & Trends
Exagen (XGN) has 9 years of Change in Account Payables data on file, last reported at -$41000.0 in Q1 2026.
- Quarterly Change in Account Payables fell 117.75% year-over-year to -$41000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$230000.0 (down 110.51% YoY) and the FY2025 annual result came in at $42000.0, down 86.36% from the prior year.
- Change in Account Payables fell to -$41000.0 in Q1 2026, from $587000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $2.3 million in Q4 2024 to a low of -$1.8 million in Q2 2025.
- A 5-year average of $75117.6 and a median of $231000.0 in 2025 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 1030.62% — and 2024, when it plunged 468.29%.
- Tracing XGN's Change in Account Payables over 5 years: stood at -$160000.0 in 2022, then soared by 1030.62% to $1.5 million in 2023, then jumped by 56.88% to $2.3 million in 2024, then slumped by 74.87% to $587000.0 in 2025, then tumbled by 106.98% to -$41000.0 in 2026.
- The last three Change in Account Payables figures came in at -$41000.0 (Q1 2026), $587000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 13.74 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -6.74 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 674,000.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -11.70 Mn |
| 10 | Exagen | 181.48 Mn | 156.88 Mn | 12.22 Mn | 242,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 242,000.00 |
| Jun 30, 2026 | 242,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Mar 31, 2026 | -41,000.00 |
| Dec 31, 2025 | 587,000.00 |
| Dec 31, 2025 | 587,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Jun 30, 2025 | -1.81 Mn |
| Mar 31, 2025 | 231,000.00 |
| Mar 31, 2025 | 231,000.00 |
| Dec 31, 2024 | 2.34 Mn |
| Dec 31, 2024 | 2.34 Mn |
| Sep 30, 2024 | -1.21 Mn |
| Sep 30, 2024 | -1.21 Mn |
| Jun 30, 2024 | 829,000.00 |
| Jun 30, 2024 | 829,000.00 |
| Mar 31, 2024 | -1.65 Mn |
| Mar 31, 2024 | -1.65 Mn |